InvestorsHub Logo
Followers 102
Posts 6264
Boards Moderated 0
Alias Born 11/12/2013

Re: ArrowsOverAthens post# 9497

Thursday, 11/08/2018 9:34:18 AM

Thursday, November 08, 2018 9:34:18 AM

Post# of 11360
Key Capital believes the planned pancreatic cancer trial will prove as groundbreaking as the Hepko-V5 Immunotherapy demonstrated in cases of advanced and terminal liver cancer.
http://www.marketwired.com/press-release/key-capital-reports-on-liver-cancer-project-progress-2219720.htm